Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
US10288629B1 · kind B1 · utility
1Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 30, 2018 |
| Grant date | May 14, 2019 |
| Priority date | — |
| Expiry date | May 30, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/048
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides a method for measuring growth hormone level in a human or animal subject, including a method of assessing pituitary-related growth hormone deficiency in a human or animal subject, after macimorelin oral administration to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.